Company Profile

Hyprotek Inc
Profile last edited on: 10/21/2021      CAGE: 62ND7      UEI: TLBWL35F22K3

Business Identifier: Improve safety and efficiency of intravenous therapy
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

665 North Riverpoint Boulevard
Spokane, WA 99202
   (509) 543-3020
Location: Single
Congr. District: 05
County: Spokane

Public Profile

Hyprotek, Inc. is a biomedical company develops patented medical technologies designed to improve the safety and efficiency of intravenous therapy. principals of the firm have developed two patent-pending medical device systems designed significantly to reduce the risk of patient infections in the clinical setting.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2020 1 NIH $251,572
Project Title: Intravascular Port and Disinfection System (Portprotek)

Key People / Management

  Patrick O Tennican -- CEO and President

Company News

There are no news available.